- Presentations
- 3
- Markets
- 1
Droxia is a brand of Hydroxyurea marketed by Waylis Therapeutics, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Hydroxyurea
- Brand owner
- Waylis Therapeutics
- Registered in
- United States
- Strengths and forms
- 200 mg capsule, 300 mg capsule, 400 mg capsule
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Droxia 200 mg capsuleOral | Waylis Therapeutics | US FDA | Available on request |
| Droxia 300 mg capsuleOral | Waylis Therapeutics | US FDA | Available on request |
| Droxia 400 mg capsuleOral | Waylis Therapeutics | US FDA | Available on request |
Equivalent brands
Other brands of Hydroxyurea.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Droxia
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.